子宫肌瘤的治疗：寻找有效的药物疗法。
Treatment for Uterine Fibroids: Searching for Effective Drug Therapies.
作者信息
Taylor Darlene K, Leppert Phyllis C
机构信息
Department of Chemistry, North Carolina Central University, 3105 M. Townes Science Building, 1801 Concord Street, Durham, NC 27707, United States ; Departments of Obstetrics and Gynecology and Pathology, Duke University School of Medicine, 242 Sands Building, Box 103206, Durham, NC 27710, United States.
出版信息
Drug Discov Today Ther Strateg. 2012;9(1):e41-e49. doi: 10.1016/j.ddstr.2012.06.001.
Abstract
Uterine fibroids are common reproductive-age benign tumors that contribute to severe morbidity and infertility. Cumulative incidence is 4 times higher in Africian-Americans compared to Caucasians and constitutes a major health disparity challenge. Fibroids are the leading indication for hysterectomy and their management averages $21 billion annually in the US. No long term minimally invasive therapies exist. Thus, promising drug therapies, their chemistry, pharmacology, and clinical efficacy, focusing first on innovative drug delivery approaches, are reviewed.
摘要
子宫肌瘤是常见的育龄期良性肿瘤，会导致严重的发病率和不孕症。与白种人相比，非裔美国人的累积发病率高出4倍，这构成了一项重大的健康差异挑战。子宫肌瘤是子宫切除术的主要指征，在美国，其治疗费用平均每年达210亿美元。目前尚无长期的微创治疗方法。因此，本文综述了有前景的药物治疗方法，包括其化学、药理学和临床疗效，首先聚焦于创新的药物递送方法。
相似文献
1
Treatment for Uterine Fibroids: Searching for Effective Drug Therapies.子宫肌瘤的治疗：寻找有效的药物疗法。
Drug Discov Today Ther Strateg. 2012;9(1):e41-e49. doi: 10.1016/j.ddstr.2012.06.001.
2
Innovative oral treatments of uterine leiomyoma.子宫平滑肌瘤的创新口服治疗方法。
Obstet Gynecol Int. 2012;2012:943635. doi: 10.1155/2012/943635. Epub 2012 Feb 16.
3
Modern management of uterine fibroids.子宫肌瘤的现代管理
Acta Obstet Gynecol Scand. 2008;87(8):812-23. doi: 10.1080/00016340802146912.
4
The management of uterine leiomyomas.子宫平滑肌瘤的管理
J Obstet Gynaecol Can. 2015 Feb;37(2):157-178. doi: 10.1016/S1701-2163(15)30338-8.
5
Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study.因良性指征行子宫切除术患者的肉瘤发病率：一项基于人群的研究。
Am J Obstet Gynecol. 2019 Feb;220(2):179.e1-179.e10. doi: 10.1016/j.ajog.2018.11.1086. Epub 2018 Nov 14.
6
Minimally invasive surgery for uterine fibroids.子宫肌瘤的微创手术。
Ginekol Pol. 2020;91(3):149-157. doi: 10.5603/GP.2020.0032.
7
Minimally invasive procedures in the management of uterine fibroids.子宫肌瘤治疗中的微创手术
Prz Menopauzalny. 2017 Dec;16(4):122-125. doi: 10.5114/pm.2017.72756. Epub 2017 Dec 30.
8
The management of uterine leiomyomas.子宫平滑肌瘤的管理
J Obstet Gynaecol Can. 2003 May;25(5):396-418; quiz 419-22.
9
Contemporary management of fibroids.子宫肌瘤的当代管理
Ann Acad Med Singap. 2003 Sep;32(5):615-23.
10
The management of uterine fibroids in women with otherwise unexplained infertility.患有不明原因不孕症的女性子宫肌瘤的管理。
J Obstet Gynaecol Can. 2015 Mar;37(3):277-285. doi: 10.1016/S1701-2163(15)30318-2.
引用本文的文献
1
Current and Emerging Treatment Options for Uterine Fibroids.子宫肌瘤的当前和新兴治疗选择。
Drugs. 2023 Dec;83(18):1649-1675. doi: 10.1007/s40265-023-01958-6. Epub 2023 Nov 3.
2
Tanshinone-I for the treatment of uterine fibroids: Molecular docking, simulation, and density functional theory investigations.丹参酮-I用于治疗子宫肌瘤：分子对接、模拟及密度泛函理论研究
Saudi Pharm J. 2023 Jun;31(6):1061-1076. doi: 10.1016/j.jsps.2023.05.002. Epub 2023 May 8.
3
Androgen Signaling in Uterine Diseases: New Insights and New Targets.雄激素信号在子宫疾病中的作用：新的见解和新的靶点。
Biomolecules. 2022 Nov 3;12(11):1624. doi: 10.3390/biom12111624.
4
Current approaches to overcome the side effects of GnRH analogs in the treatment of patients with uterine fibroids.当前克服 GnRH 类似物在子宫肌瘤治疗中副作用的方法。
Expert Opin Drug Saf. 2022 Apr;21(4):477-486. doi: 10.1080/14740338.2022.1989409. Epub 2021 Oct 20.
5
Enzyme Therapy: Current Challenges and Future Perspectives.酶疗法：当前的挑战和未来的展望。
Int J Mol Sci. 2021 Aug 25;22(17):9181. doi: 10.3390/ijms22179181.
6
Using rheology to quantify the effects of localized collagenase treatments on uterine fibroid digestion.利用流变学定量分析局部胶原酶治疗对子宫肌瘤消化的影响。
Acta Biomater. 2021 Oct 15;134:443-452. doi: 10.1016/j.actbio.2021.08.003. Epub 2021 Aug 8.
7
Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids.细胞外基质和 Hippo 信号通路作为抗纤维化合物治疗子宫肌瘤的靶点。
Clin Transl Med. 2021 Jul;11(7):e475. doi: 10.1002/ctm2.475.
8
Organotypic culture as a research and preclinical model to study uterine leiomyomas.器官型培养作为研究和临床前模型研究子宫平滑肌瘤。
Sci Rep. 2020 Mar 23;10(1):5212. doi: 10.1038/s41598-020-62158-w.
9
Adlay ( L. var. Stapf.) Hull Extract and Active Compounds Inhibit Proliferation of Primary Human Leiomyoma Cells and Protect against Sexual Hormone-Induced Mice Smooth Muscle Hyperproliferation.薏苡（L. var. Stapf.）种皮提取物及其活性成分可抑制原代人平滑肌瘤细胞增殖并防止性激素诱导的小鼠平滑肌过度增殖。
Molecules. 2019 Apr 19;24(8):1556. doi: 10.3390/molecules24081556.
10
Circulating Sex Hormones and Risk of Uterine Fibroids: Study of Women's Health Across the Nation (SWAN).循环性激素与子宫肌瘤风险：全国女性健康研究（SWAN）
J Clin Endocrinol Metab. 2016 Jan;101(1):123-30. doi: 10.1210/jc.2015-2935. Epub 2015 Dec 15.
本文引用的文献
1
Novel 3-aryl indoles as progesterone receptor antagonists for uterine fibroids.新型3-芳基吲哚类化合物作为子宫肌瘤的孕激素受体拮抗剂
ACS Med Chem Lett. 2010 Dec 9;2(2):148-53. doi: 10.1021/ml100220b. eCollection 2011 Feb 10.
2
Innovative oral treatments of uterine leiomyoma.子宫平滑肌瘤的创新口服治疗方法。
Obstet Gynecol Int. 2012;2012:943635. doi: 10.1155/2012/943635. Epub 2012 Feb 16.
3
Term myometrium is characterized by increased activating epigenetic modifications at the progesterone receptor-A promoter.术语“子宫肌层”的特征是孕激素受体 A 启动子上激活的表观遗传修饰增加。
Mol Hum Reprod. 2012 Aug;18(8):401-9. doi: 10.1093/molehr/gas012. Epub 2012 Feb 27.
4
Ulipristal acetate versus placebo for fibroid treatment before surgery.醋酸乌利司他用于手术前子宫肌瘤治疗：与安慰剂对照。
N Engl J Med. 2012 Feb 2;366(5):409-20. doi: 10.1056/NEJMoa1103182.
5
Treatment of uterine myoma with 5 or 10mg mifepristone daily during 6 months, post-treatment evolution over 12 months: double-blind randomised clinical trial.每日口服 5 或 10mg 米非司酮治疗子宫肌瘤 6 个月，治疗后 12 个月的随访：双盲随机临床试验。
Eur J Obstet Gynecol Reprod Biol. 2012 Apr;161(2):202-8. doi: 10.1016/j.ejogrb.2011.12.018. Epub 2012 Jan 23.
6
Proteoglycans of uterine fibroids and keloid scars: similarity in their proteoglycan composition.子宫肌瘤和瘢痕疙瘩的蛋白聚糖：其蛋白聚糖组成的相似性。
Biochem J. 2012 Apr 15;443(2):361-8. doi: 10.1042/BJ20111996.
7
The estimated annual cost of uterine leiomyomata in the United States.估计美国子宫平滑肌瘤的年度成本。
Am J Obstet Gynecol. 2012 Mar;206(3):211.e1-9. doi: 10.1016/j.ajog.2011.12.002. Epub 2011 Dec 11.
8
Contraceptives with novel benefits.具有新益处的避孕药具。
Expert Opin Investig Drugs. 2012 Jan;21(1):83-90. doi: 10.1517/13543784.2012.642368. Epub 2011 Dec 8.
9
Temperature-responsive biocompatible copolymers incorporating hyperbranched polyglycerols for adjustable functionality.包含超支化聚甘油的温度响应性生物相容性共聚物，用于可调节功能。
J Funct Biomater. 2011 Aug 23;2(3):173-94. doi: 10.3390/jfb2030173.
10
Emerging indications for the levonorgestrel-releasing intrauterine system (LNG-IUS).左炔诺孕酮宫内节育系统（LNG-IUS）的新适应证。
Acta Obstet Gynecol Scand. 2012 Jan;91(1):3-9. doi: 10.1111/j.1600-0412.2011.01303.x. Epub 2011 Nov 9.
Zotero 插件